Saturday, November 29, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Eutelsat Shareholders Face Significant Dilution Amid Capital Increase

Robert Sasse by Robert Sasse
November 29, 2025
in Analysis, European Markets, Telecommunications
0
Eutelsat Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

In a surprising move, JPMorgan has upgraded its rating on Eutelsat shares despite the satellite operator currently undergoing a substantial capital increase. The stock has suffered dramatic losses since 2022, declining more than 80 percent from previous highs. According to the American banking institution, the most severe downside risks now appear to be priced into the current valuation. However, ongoing rights issues present existing shareholders with the threat of considerable equity dilution.

Strategic Shifts Following Price Decline

The French satellite company finds itself at a critical juncture as analysts reassess their positions. JPMorgan raised its recommendation from “Underweight” to “Neutral” while establishing a price target of €1.90. Notably, this target falls below the current trading price of approximately €2.20. This positioning suggests the bank believes the steepest decline may have passed, representing a cautious reconciliation after years of downward momentum.

Independent research firm AlphaValue maintained its “Buy” recommendation but implemented a sharp reduction in its price outlook, cutting it from €4.01 to €2.89. The firm cited the substantial dilution effect from the current capital measure as an unavoidable factor in its revised assessment.

Capital Raise Details and Shareholder Dilemma

The rights issue, which commenced recently, presents existing investors with a difficult choice:

Should investors sell immediately? Or is it worth buying Eutelsat?

  • Subscription price: €1.35 per new share – representing a 58% discount
  • Ratio: 8 new shares for every 11 existing shares held
  • Subscription period: Through December 9
  • Fundraising goal: €670 million earmarked for debt reduction and OneWeb integration

Shareholders who choose not to participate will experience meaningful dilution of their holdings. The significant spread between the market price and subscription rate is also expected to attract arbitrage traders, potentially increasing near-term volatility.

Changing Ownership Landscape

The French government has substantially expanded its stake in Eutelsat, now holding 29.65% of the company. Meanwhile, Bharti Space Limited has seen its ownership decrease to 17.88%. This shift solidifies strategic control in Paris, signaling a clearer focus on government satellite initiatives such as the IRIS² project.

Eutelsat shares currently trade at €2.20, showing modest gains in recent sessions. Despite this slight recovery, the stock remains highly speculative. Company leadership has committed to reducing leverage to 2.5 times EBITDA by the 2025/26 fiscal year while targeting 50% revenue growth in its low Earth orbit business segment. Whether this strategic turnaround will prove successful remains uncertain. The coming weeks will reveal whether this capital infusion serves as a genuine lifeline or merely a temporary reprieve.

Ad

Eutelsat Stock: Buy or Sell?! New Eutelsat Analysis from November 29 delivers the answer:

The latest Eutelsat figures speak for themselves: Urgent action needed for Eutelsat investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 29.

Eutelsat: Buy or sell? Read more here...

Tags: Eutelsat
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Rimini Stock
Analysis

Rimini Street Shares: Opportunity Amidst Volatility?

November 29, 2025
Newmont Mining Stock
Analysis

Newmont Stock: Institutional Investors Bet Big on Gold’s Record Run

November 29, 2025
Natural Gas Services Group Stock
Analysis

Natural Gas Services Group Shares Surge as Bulls Take Charge

November 29, 2025
Next Post
Cardano Stock

Cardano's Institutional Validation Amid Network Turbulence

Redcare Pharmacy Stock

Can New Leadership Revive Redcare Pharmacy's Prospects?

Natural Gas Services Group Stock

Natural Gas Services Group Shares Surge as Bulls Take Charge

Recommended

Vail Resorts Faces Setbacks in Q2 Financial Results

2 years ago
Trevi Therapeutics Stock

Trevi Therapeutics Shares Surge Ahead of Key Clinical Data Release

2 months ago
Sylvamo Stock

Sylvamo Stock: A Contested Path to Recovery

1 week ago
IBM Stock

IBM’s Quantum Ambition: A High-Stakes Transformation

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Natural Gas Services Group Shares Surge as Bulls Take Charge

Can New Leadership Revive Redcare Pharmacy’s Prospects?

Cardano’s Institutional Validation Amid Network Turbulence

Eutelsat Shareholders Face Significant Dilution Amid Capital Increase

Palantir Shares Face a Harsh Reality Check

Robinhood’s Bold Bet on Prediction Markets

Trending

Rimini Stock
Analysis

Rimini Street Shares: Opportunity Amidst Volatility?

by Andreas Sommer
November 29, 2025
0

Rimini Street's stock presents investors with a complex picture. Currently trading around $3.83, the shares have declined...

Rubrik Stock

Cybersecurity Firm Rubrik Gains Investor Attention Ahead of Earnings

November 29, 2025
Newmont Mining Stock

Newmont Stock: Institutional Investors Bet Big on Gold’s Record Run

November 29, 2025
Natural Gas Services Group Stock

Natural Gas Services Group Shares Surge as Bulls Take Charge

November 29, 2025
Redcare Pharmacy Stock

Can New Leadership Revive Redcare Pharmacy’s Prospects?

November 29, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rimini Street Shares: Opportunity Amidst Volatility?
  • Cybersecurity Firm Rubrik Gains Investor Attention Ahead of Earnings
  • Newmont Stock: Institutional Investors Bet Big on Gold’s Record Run

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com